A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers

This study has been completed.

Study NCT00645554 Information provided by Xian-Janssen Pharmaceutical Ltd.

First Received: March 24, 2008 Last Updated: May 18, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2004
Estimated Primary Completion Date:	No date given